L-Cystine

L-Cystine
Product Name L-Cystine
CAS No.: 56-89-3
Catalog No.: CFN70150
Molecular Formula: C6H12N2O4S2
Molecular Weight: 240.3 g/mol
Purity: >=98%
Type of Compound: Alkaloids
Physical Desc.: Powder
Targets: GSH-Px | SOD | H1N1 | TNF-α
Source: The culture product of Escherichia coli.
Solvent: Chloroform, Dichloromethane, Ethyl Acetate, DMSO, Acetone, etc.
Price: $30/20mg
L-Cystine can improve hyperlipidemia by restoring LPL and HSL activities.L-Cystine protects against the toxicity of PQ by maintaining reduced glutathione levels in the cells. Co-administration of l-cystine and l-theanine before vaccination may enhance the immune response to influenza vaccine in elderly subjects with low serum total protein or hemoglobin.
Inquire / Order: manager@chemfaces.com
Technical Inquiries: service@chemfaces.com
Tel: +86-27-84237783
Fax: +86-27-84254680

Address:
1 Building, No. 83, CheCheng Rd., Wuhan Economic and Technological Development Zone, Wuhan, Hubei 430056, PRC
Providing storage is as stated on the product vial and the vial is kept tightly sealed, the product can be stored for up to 24 months(2-8C).

Wherever possible, you should prepare and use solutions on the same day. However, if you need to make up stock solutions in advance, we recommend that you store the solution as aliquots in tightly sealed vials at -20C. Generally, these will be useable for up to two weeks. Before use, and prior to opening the vial we recommend that you allow your product to equilibrate to room temperature for at least 1 hour.

Need more advice on solubility, usage and handling? Please email to: service@chemfaces.com

The packaging of the product may have turned upside down during transportation, resulting in the natural compounds adhering to the neck or cap of the vial. take the vial out of its packaging and gently shake to let the compounds fall to the bottom of the vial. for liquid products, centrifuge at 200-500 RPM to gather the liquid at the bottom of the vial. try to avoid loss or contamination during handling.
  • Microb Pathog.2024, 189:106609.
  • Evid Based Complement Alternat Med.2022, 2022:3483511
  • Biomed Pharmacother.2021, 137:111362.
  • J Ethnopharmacol.2019, 228:132-141
  • Chemistry of Natural Compounds2018, 54(3):572-576
  • Industrial Crops and Products2019, 140:111612
  • Asian J Beauty Cosmetol2016, 14(3):249-257
  • BMB Rep.2020, 53(4):218-222.
  • J Pharm Biomed Anal.2024, 241:115990.
  • Kangwon National University2022, 37(1):29-37
  • Oxymatrine

    Catalog No: CFN99805
    CAS No: 16837-52-8
    Price: $40/20mg
    Malvidin-3-O-glucoside chloride

    Catalog No: CFN92049
    CAS No: 7228-78-6
    Price: $238/10mg
    Nobiletin

    Catalog No: CFN98726
    CAS No: 478-01-3
    Price: $30/20mg
    Genipin

    Catalog No: CFN99142
    CAS No: 6902-77-8
    Price: $40/20mg
    Sweroside

    Catalog No: CFN99455
    CAS No: 14215-86-2
    Price: $40/20mg
    Cytotechnology, 2010, 62(3):225-233.
    Effects of sulfur amino acids, L: -methionine, L: -cystine and L: -cysteine on lipoprotein lipase and hormone-sensitive lipase in differentiated mouse 3T3-L1 adipocytes.[Reference: WebLink]
    Rats subcutaneously implanted with AH109A hepatoma cells show hyperlipidemia with high concentrations of serum triglyceride and nonesterified fatty acid, suppression of lipoprotein lipase (LPL), and elevation of hormone-sensitive lipase (HSL) activities during the growth of the hepatoma. Supplementation of the diet with sulfur amino acids such as L -methionine (Met) and L-Cystine (Cys) improved hyperlipidemia by restoring LPL and HSL activities.
    METHODS AND RESULTS:
    In the present study, we have attempted to examine the effects of sulfur amino acids on the activity and mRNA level of LPL and the activity of HSL using 3T3-L1 cells, which are known to differentiate to adipocytes. The adipocytes were incubated with various concentrations of Met, Cys or L -cysteine (CysH) in the absence or presence of tumor necrosis factor-alpha (TNF-alpha). LPL activity was suppressed by TNF-alpha. In the absence of TNF-alpha, Met, Cys and CysH did not change the LPL activity. In the presence of TNF-alpha, Met and Cys significantly increased the LPL activity, and Met also enhanced the LPL mRNA level. HSL activity was also suppressed by TNF-alpha. In the absence of TNF-alpha, Met enhanced the HSL activity. In the presence of TNF-alpha, Met, Cys and CysH suppressed the HSL activity. Sulfur amino acids such as Met, Cys and CysH affected the LPL activity, mRNA level, and HSL activity in 3T3-L1 adipocytes.
    CONCLUSIONS:
    Some of these effects of sulfur amino acids were different between LPL and HSL, between the absence and the presence of TNF-alpha, and between 3T3-L1 adipocytes and the adipose tissue from rats.
    Geriatrics & Gerontology International, 2010, 8(4):243-250.
    Co-administration of L-cystine and L-theanine enhances efficacy of influenza vaccination in elderly persons: Nutritional status-dependent immunogenicity.[Reference: WebLink]
    The immune response to influenza vaccine is attenuated in elderly persons, though they are at greatest risk for morbidity and mortality by influenza virus infection.
    METHODS AND RESULTS:
    Experimental studies demonstrate that co-administration of L-Cystine and l-theanine enhanced antigen-specific production of immunoglobulin in aged mice infected with influenza virus. We thus investigated the effect of L-Cystine and l-theanine on antibody induction by influenza vaccines in elderly persons. Residents in a nursing home were randomly allocated to L-Cystine and l-theanine (n = 32) or placebo (n = 33). The test substances were administered p.o. for 14 days before immunization. Serum influenza virus antibody titers were measured before and 4 weeks after vaccination. Vaccination significantly elevated hemagglutination inhibition (HI) titers for all the three strains of influenza viruses (A/New Caledonia [H1N1], A/New York [H3N2] and B/Shanghai) in both groups. HI titers after vaccination were not significantly different between the two groups for either strain. Also, the seroconversion rate was not significantly different between the two groups in the aggregate. A stratified analysis showed that the rate of seroconversion was significantly greater in the L-Cystine and l-theanine group compared with the placebo group for influenza virus A (H1N1) among subjects with low serum total protein (63% vs 10%, P < 0.05) or low hemoglobin (71% vs 9%, P < 0.05).
    CONCLUSIONS:
    Co-administration of L-Cystine and l-theanine before vaccination may enhance the immune response to influenza vaccine in elderly subjects with low serum total protein or hemoglobin.
    Toxicology Letters, 1992, 60(1):75-82.
    Effect of l-cystine on toxicity of paraquat in mice.[Reference: WebLink]

    METHODS AND RESULTS:
    The protective effect of L-Cystine on the toxicity of paraquat (PQ) in mice was studied. Lipid peroxidation in the lung significantly increased after oral administration of PQ (200 mgkg) and the increase in lipid peroxidation was prevented by L-Cystine treatment (300 mgkg). PQ administration produced an increase in Superoxide dismutase (SOD) activity and a decrease in glutathione peroxidase (GSH-Px) activity in the lung at 24 h after PQ. L-Cystine treatment significantly prevented the changes in SOD and GSH-Px activity in the lung after PQ. L-Cystine treatment prevented the decrease in non-protein sulfhydryl (NP-SH) content in the lung after PQ administration. The tissue distribution and excretion of PQ after PQ administration were not changed by L-Cystine treatment. Plasma aspartate aminotransferase activity did not change after PQ administration.
    CONCLUSIONS:
    These results suggest that L-Cystine protects against the toxicity of PQ by maintaining reduced glutathione levels in the cells.
    Buddlenoid A

    Catalog No: CFN95025
    CAS No: 142750-32-1
    Price: $368/5mg
    Rhamnocitrin 3-glucoside

    Catalog No: CFN95134
    CAS No: 41545-37-3
    Price: $318/10mg
    ent-16beta,17-dihydroxy-9(11)-kauren-19-oic acid

    Catalog No: CFN95172
    CAS No: 55483-24-4
    Price: $318/10mg
    Epischisandrone

    Catalog No: CFN95212
    CAS No: 98619-26-2
    Price: $413/5mg
    N1,N5,N10-(Z)-tri-p-coumaroylspermidine

    Catalog No: CFN95253
    CAS No: 131086-78-7
    Price: $238/5mg
    Phyllanthusiin C

    Catalog No: CFN95260
    CAS No: 142674-52-0
    Price: $318/5mg
    Cagayanin

    Catalog No: CFN95480
    CAS No: 99096-51-2
    Price: $318/20mg
    Kihadanin D

    Catalog No: CFN95482
    CAS No: 2770024-83-2
    Price: $413/5mg
    Massonianoside D

    Catalog No: CFN95500
    CAS No: 85115-04-4
    Price: $318/10mg
    Mahuannin B

    Catalog No: CFN95554
    CAS No: 82796-37-0
    Price: $318/5mg